Llwytho...
Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice
CL 316,243, a β(3)-adrenergic agonist, was developed as an antiobesity and diabetes drug and causes rapid decreases in blood glucose levels in mice. The mechanisms mediating this effect have not been fully elucidated; thus, the purpose of the current study was to examine the role of fatty acids and...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Physiological Society
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187028/ https://ncbi.nlm.nih.gov/pubmed/25096179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00287.2014 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|